Lithium and coronaviral infections. A scoping review. [version 2; peer review: 3 approved]
Título
Lithium and coronaviral infections. A scoping review. [version 2; peer review: 3 approved]
Autor
Jarosław Walkowiak, Jan K Nowak
Descripción
The current rapid spread of the novel coronavirus (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) calls for a rapid response from the research community. Lithium is widely used to treat bipolar disorder, but has been shown to exhibit antiviral activity. This brief review took a systematic approach to identify six in vitro studies reporting on the influence of lithium on coronaviral infections. We propose mechanistic investigation of the influence of lithium – alone and with chloroquine – on the SARS-CoV-2 infection.
Fecha
2020
Identificador
DOI: 10.12688/f1000research.22299.2
Fuente
F1000Research
Editor
F1000 Research Ltd
Cobertura
Biology (General), Medicine
Archivos
Colección
Citación
Jarosław Walkowiak, Jan K Nowak, “Lithium and coronaviral infections. A scoping review. [version 2; peer review: 3 approved],” SOCICT Open, consulta 19 de abril de 2026, https://socictopen.socict.org/items/show/3614.
Position: 9439 (26 views)